Page 4 - சிகிச்சை பொருட்கள் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novavax COVID-19 vaccine production set back due to supply shortages Posted 5 AprApril 2021 at 2:06pm Data released in March from the UK trial showed the vaccine to be highly effective against COVID-19. ( Print text only Cancel Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages, dealing another blow to the federal government s rollout plans. Key points: Novavax is one of three companies the federal government struck a deal with to distribute COVID-19 vaccines in Australia It will need to be imported to Australia because of a lack of capable vaccine manufacturers

South africaUnited statesUnited kingdomPaul kellyStan erckMark womackTherapeutic goods associationEuropean unionNovavax incAmy speakMedical officer paul kellyCovid 19ஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்பால் கெல்லிஸ்டான் ஏற்க்க்